PTGX

NASDAQStock$155.81-1.53 (-0.97%)
Mkt Cap 10.0BP/E Div Yield Beta 1.79Vol 506.1K
52W$56.04
$158.62

ETFs That Hold PTGX (Protagonist Therapeutics, Inc.)

1M

+12.02%

3M

+56.21%

6M

+78.94%

YTD

+77.72%

1Y

+175.55%

3Y

+693.34%

5Y

+212.44%

ETFs That Hold PTGX

Protagonist Therapeutics, Inc. is held by 127 ETFs. The largest position by market value is in IJR (iShares Core S&P Small-Cap ETF).

ETFFund NameWeight
ITDCiShares LifePath Target Date 2035 ETF0.00%
AVTMAvantis Total Equity Markets ETF 10.00%
ITDHiShares LifePath Target Date 2060 ETF0.01%
ITDIiShares LifePath Target Date 2065 ETF0.01%
ITDBiShares LifePath Target Date 2030 ETF0.00%
ITDJiShares LifePath Target Date 2070 ETF0.01%
IRTRiShares LifePath Retirement ETF0.00%

Excludes leveraged and inverse ETFs.

PreviousPage 7 of 7

Frequently Asked Questions

How many ETFs hold PTGX?
Protagonist Therapeutics, Inc. (PTGX) is held by 127 ETFs (excluding leveraged and inverse funds). The largest position by market value is in IJR (iShares Core S&P Small-Cap ETF).
What is the largest ETF that holds PTGX?
By fund size, IJR (iShares Core S&P Small-Cap ETF) with $113.45B in AUM holds 0.50% of its portfolio in PTGX, representing $559.7M in market value.
What percentage of PSCH is PTGX?
PTGX makes up 4.63% of PSCH (Invesco S&P SmallCap Health Care ETF), making it one of the largest positions in that fund.
Is PTGX in the S&P 500?
PTGX is not currently a component of the S&P 500 index based on available ETF holdings data.
FREE DOWNLOAD

The Beginner's Guide to ETFs

20 pages. Zero fluff. Everything you need to start investing in ETFs.

No spam. Unsubscribe anytime.